Sort   by:  
 Page size 
UnknownHyperactive CDK2 Activity in Basal-like Breast Cancer Imposes a Genome Integrity Liability that Can Be Exploited by Targeting DNA Polymerase ε.
Not available
S-EPMC7687292 | biostudies-literature
UnknownDeep Learning and Pathomics Analyses Reveal Cell Nuclei as Important Features for Mutation Prediction of BRAF-Mutated Melanomas.
Not available
S-EPMC9054943 | biostudies-literature
UnknownImpact of Propofol Exposure on Neurocognitive Outcomes in Children With High-Risk B ALL: A Children's Oncology Group Study.
Not available
S-EPMC11616431 | biostudies-literature
UnknownBlinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children.
Not available
S-EPMC11864901 | biostudies-literature
UnknownFatigue in levodopa-naive subjects with Parkinson disease.
Not available
S-EPMC2937041 | biostudies-literature
Unknownrs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology.
Not available
S-EPMC6163881 | biostudies-literature
UnknownSafety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation.
Not available
S-EPMC11249957 | biostudies-literature
UnknownApolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab.
Not available
S-EPMC9422774 | biostudies-literature
UnknownGuidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Not available
S-EPMC4835977 | biostudies-literature
UnknownLipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol.
Not available
S-EPMC8822604 | biostudies-literature
Sort   by:  
 Page size